Succeeding in the UK Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
About This Report
This new 281-page report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for microbiology testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product
and financial literature, as well as the proprietary data files was conducted.
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VIII. UK: Market Size, Growth and Major Suppliers
Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako
List Of Tables
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
U.K.
Adenovirus
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Influenza Testing Market Diagnostics Sales
by Major Supplier
U.K.
Legionella Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Mononucleosis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Mycoplasma Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Mycoplasma Testing Market Diagnostics Sales
by Major Supplier
U.K.
Pneumonia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Pneumonia Testing Market Diagnostics Sales
by Major Supplier
U.K.
RSV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
RSV Testing Market Diagnostics Sales by Major Supplier
U.K.
Tuberculosis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Tuberculosis Testing Market Diagnostics Sales
by Major Supplier
Succeeding in the Yersinia Diagnostics Market, 2019-2023: USA, Europe, Japan--Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--Hospitals, Commercial and Public Health Labs, POC Locations
This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Yersinia tests performed
View ReportSucceeding in the Vibrio Diagnostics Market, 2019-2023: USA, Europe, Japan--Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--Hospitals, Commercial and Public Health Labs, POC Locations
This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Vibrio tests performed
View ReportInfluenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential
Influenza Vaccines in the United States Market Size, Trends, Opportunities and Growth Potential market research report available in single user pdf license with Aarkstore Enterprise at USD 1690
View ReportMachine Learning in the Life Sciences
Report Includes:- An overview of global market outlook for machine learning in life sciences- Identification of machine learning applications in life science sector- Recent achievements in life science due to
View ReportFill The Form For Sample Request